Patients’ perspectives on exposure to environmental contaminants: a missing piece in pulmonary rehabilitation? Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 2 Year: 2020
Biomarkers of inhalation - what’s new and what is useful in smoking cessation and reduction trials? Source: Annual Congress 2003 - PG20 - Smoking reduction and smoking cessation - an update and suggestions for future studies Year: 2003
Altered metabolism in pulmonary hypertension: fuelling the fire or just smoke? Source: Eur Respir J, 55 (4) 2000447; 10.1183/13993003.00447-2020 Year: 2020
Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers Source: Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020 Year: 2020
Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers Source: Eur Respir J, 55 (5) 2001122; 10.1183/13993003.01122-2020 Year: 2020
Late Breaking Abstract - Identifying and addressing patient beliefs driving SABA use and over-reliance Source: International Congress 2019 – Novel findings from asthma clinical trials Year: 2019
Does inhaled corticosteroid use affect the risk of ?COVID-19-related death? Source: Breathe, 17 (1) 200275; 10.1183/20734735.0275-2020 Year: 2021
When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma? Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021 Year: 2021
Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? Source: Eur Respir J 2004; 24: 1-2 Year: 2004
Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow Source: Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021 Year: 2021
The fog, the attractive and the addictive: pulmonary effects of vaping with a focus on the contribution of each major vaping liquid constituent Source: Eur Respir Rev, 29 (157) 200268; 10.1183/16000617.0268-2020 Year: 2020
Systemic biomarkers in electronic cigarette users: implications for noninvasive assessment of vaping-associated pulmonary injuries Source: ERJ Open Res, 5 (4) 00182-2019; 10.1183/23120541.00182-2019 Year: 2019
Immediate effects of smoking: does tobacco and electronic cigarettes differ? Source: International Congress 2019 – Challenges in tobacco control and cessation Year: 2019
Assessment of efficacy of pulmonary rehabilitation: which outcomes do we need to focus on? Source: ERS Course 2017 Year: 2017
Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018
Whither pulmonary rehabilitation? Will alternative modes help or hurt? Source: Eur Respir J, 52 (4) 1801678; 10.1183/13993003.01678-2018 Year: 2018
Current clinical management of smoke inhalation injuries: a reality check Source: Eur Respir J, 52 (6) 1802163; 10.1183/13993003.02163-2018 Year: 2018
Does short-term treatment intensification influence long-term treatment effects on health status in COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005
Impact of pulmonary rehabilitation: can we identify good responders? Source: Eur Respir J 2004; 24: Suppl. 48, 244s Year: 2004
Minimising the environmental impact of inhaled therapies Source: Eur Respir J, 55 (5) 2000721; 10.1183/13993003.00721-2020 Year: 2020